Leukocyte Immunoglobulin-Like Receptor B3 (LILRB3) (C-Term) Peptide
LILRB3
Reactivity: Human
Host: Synthetic
BP, WB
-
- Target See all LILRB3 products
- LILRB3 (Leukocyte Immunoglobulin-Like Receptor B3 (LILRB3))
- Protein Region
- C-Term
- Origin
- Human
-
Source
- Synthetic
- Application
- Blocking Peptide (BP), Western Blotting (WB)
- Sequence
- LFLLLFLLLR RQRHSKHRTS DQRKTDFQRP AGAAETEPKD RGLLRRSSPA
- Characteristics
- This is a synthetic peptide designed for use in combination with anti-LIRB3 Antibody. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
-
-
- Application Notes
- Optimal working dilution should be determined by the investigator.
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Reconstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
- Storage
- -20 °C
- Storage Comment
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
- Target
- LILRB3 (Leukocyte Immunoglobulin-Like Receptor B3 (LILRB3))
- Background
-
LIRB3 may act as receptor for class I MHC antigens. It becomes activated upon coligation of LILRB3 and immune receptors, such as FCGR2B and the B-cell receptor. Down-regulates antigen-induced B- cell activation by recruiting phosphatases to its immunoreceptor tyrosine-based inhibitor motifs (ITIM).
Alias Symbols: LILRB3,ILT5, LIR3,
Protein Size: 631 - Gene ID
- 102725035
- NCBI Accession
- XP_006726377
- UniProt
- O75022
-
You are here:
